NL4-3 mCherry Luciferase17833 bp80016002400320040004800560064007200800088009600104001120012000128001360014400152001600016800176005' LTR (truncated)HIV-1 PsiHIV-1 polProtein TatenvmCherryT2AluciferaseIRES2Protein Nef3' LTRL4440oriAmpRAmpR promoterpBRforEcopGEX 3'pRS-marker

基本信息

The NL4 - 3 mCherry Luciferase vector is an important tool for studying HIV - 1 latency.

It combines mCherry and Luciferase genes connected by a T2A ribosomal skip sequence. Under the same LTR - driven mRNA, they are expressed as separate proteins with Nef under an IRES element.

This dual reporter gene system allows simultaneous monitoring of activated cell number (mCherry) and reactivation strength (Luciferase). It accurately reflects HIV - 1 states, providing a comprehensive perspective for latency mechanism study. Its advantages include comprehensive information acquisition, rapid latency establishment and reactivation detection in primary CD4 T cells and different subsets, and broad application prospects for evaluating activator effects and studying subset differences, supporting HIV latency research and treatment strategy development.
载体名称
NL4-3 mCherry Luciferase
载体抗性
Ampicillin
载体长度
17833 bp
载体类型
Lentiviral
复制子
ori
筛选标记
mCherry, Luciferase
启动子
EF-1 alpha– driven mCherry:Puromycin
克隆方法
Restriction Enzyme
5'引物
from pNLENG1 5'
3'引物
from pNLENG1 3'
感受态
DH10B
培养温度
37℃

质粒操作方法

质粒复溶方法

  1. 发货形式:质粒干粉,常温运输,收到后请于 -20 ℃ 保存,先转化提质粒再使用。
  2. 收到干粉后先 5000 rpm 离心 1 min,加入 20 μl ddH₂O 溶解。质粒复测浓度与标称值可能有差距,这通常来自干粉在管中的位置、复溶效率、测量偏差与管壁吸附,建议先转化提质粒后再使用。
  3. 取 1 支 100 μl 感受态细胞冰上解冻 10 min,加入 2 μl 质粒,冰浴 30 min,42 ℃ 热激 60 s(不要摇动),再冰浴 2 min。
  4. 加入 900 μl 无抗生素 LB 液体培养基,180 rpm、37 ℃ 振荡培养 45 min(30 ℃ 培养 1–1.5 h)。
  5. 6000 rpm 离心 5 min,保留约 100 μl 上清重悬菌体,涂布到对应抗性的 LB 平板。
  6. 平板倒置 37 ℃ 培养 14 h(30 ℃ 则 20 h)。菌落过多可稀释质粒后再转化;无菌落可增加至 10 μl 质粒。建议先转克隆感受态、重提质粒后再导入表达感受态。
  7. 挑取单菌落接种 LB 液体培养基,加入对应抗生素,220 rpm 振荡培养 14 h,按试剂盒说明提取质粒。

通用质粒转化方法

  1. 取100 μL感受态细胞置于冰上解冻10 min,加入2 μL质粒,冰浴30 min;随后42 ℃热激60 s,期间不要晃动,再冰浴2 min。
  2. 加入900 μL无抗LB液体培养基,37 ℃、180 rpm振荡培养45 min(30 ℃条件下则培养1–1.5 h)。
  3. 6000 rpm离心5 min,弃上清,仅保留100 μL上清重悬菌体沉淀,涂布于对应质粒抗性的LB平板上。
  4. 平板倒置培养,37 ℃培养14 h,或30 ℃培养20 h。
  5. 挑取单菌落至LB液体培养基中,加入对应抗生素,220 rpm振荡培养14 h;根据实验需求及质粒提取试剂盒说明书提取质粒。

参考文献

  • Lassen KG, Hebbeler AM, Bhattacharyya D, Lobritz MA, Greene WC. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs. PLoS One. 2012;7(1):e30176. doi: 10.1371/journal.pone.0030176. Epub 2012 Jan 24. PMID: 22291913; PMCID: PMC3265466.

NL4-3 mCherry Luciferase 质粒 (编号: V000994) 注释

LOCUS       V000994                17833 bp    DNA     circular SYN 13-MAY-2021
DEFINITION  Exported.
ACCESSION   V000994
VERSION     V000994
KEYWORDS    NL4-3 mCherry Luciferase
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
            .
REFERENCE   1  (bases 1 to 17833)
  AUTHORS   Lassen KG, Hebbeler AM, Bhattacharyya D, Lobritz MA, Greene WC
  TITLE     A flexible model of HIV-1 latency permitting evaluation of many
            primary CD4 T-cell reservoirs.
  JOURNAL   PLoS One. 2012;7(1):e30176. doi: 10.1371/journal.pone.0030176. Epub
            2012 Jan 24.
   PUBMED   22291913
REFERENCE   2  (bases 1 to 17833)
  TITLE     Direct Submission
REFERENCE   3  (bases 1 to 17833)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "PLoS One.";
            date: "2012"; pages: "
            10.1371/journal.pone.0030176. Epub 2012 Jan 24"
            SGRef: number: 2; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..17833
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     LTR             377..634
                     /label="5' LTR (truncated)"
                     /note="truncated 5' long terminal repeat (LTR) from HIV-1"
     misc_feature    681..806
                     /label="HIV-1 Psi"
                     /note="packaging signal of human immunodeficiency virus
                     type 1"
     CDS             790..2289
                     /label="HIV-1 gag"
                     /note="gag protein from human immunodeficiency virus 1"
     CDS             2085..5093
                     /label="HIV-1 pol"
                     /note="pol protein from human immunodeficiency virus 1"
     CDS             5041..5616
                     /gene="vif"
                     /label="Virion infectivity factor"
                     /note="Virion infectivity factor from Human
                     immunodeficiency virus type 1 group M subtype B (isolate
                     NY5). Accession#: P12504"
     CDS             5830..6003
                     /note="Protein Tat from Human immunodeficiency virus type 1
                     group M subtype B (isolate BH5). Accession#: P04612"
                     /label="Protein Tat"
     CDS             6221..8779
                     /gene="env"
                     /label="Envelope glycoprotein gp160"
                     /note="Envelope glycoprotein gp160 from Human
                     immunodeficiency virus type 1 group M subtype B (isolate
                     MFA). Accession#: P19551"
     CDS             8787..9494
                     /label="mCherry"
                     /note="monomeric derivative of DsRed fluorescent protein
                     (Shaner et al., 2004)"
     CDS             9501..9554
                     /codon_start=1
                     /product="2A peptide from Thosea asigna virus capsid
                     protein"
                     /label="T2A"
                     /note="Eukaryotic ribosomes fail to insert a peptide bond
                     between the Gly and Pro residues, yielding separate
                     polypeptides."
                     /translation="EGRGSLLTCGDVEENPGP"
     CDS             9558..11204
                     /label="luciferase"
                     /note="firefly luciferase"
     misc_feature    11212..11794
                     /label="IRES2"
                     /note="internal ribosome entry site (IRES) of the
                     encephalomyocarditis virus (EMCV)"
     CDS             11795..11821
                     /gene="nef"
                     /label="Protein Nef"
                     /note="Protein Nef from Human immunodeficiency virus type 1
                     group M subtype D (isolate Z84). Accession#: P12481"
     LTR             12084..12717
                     /label="3' LTR"
                     /note="3' long terminal repeat (LTR) from HIV-1"
     primer_bind     complement(14357..14374)
                     /label="L4440"
                     /note="L4440 vector, forward primer"
     rep_origin      complement(14528..15116)
                     /direction=LEFT
                     /label="ori"
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                     replication"
     CDS             complement(15290..16147)
                     /label="AmpR"
                     /note="beta-lactamase"
     promoter        complement(16148..16252)
                     /label="AmpR promoter"
     primer_bind     16320..16338
                     /label="pBRforEco"
                     /note="pBR322 vectors, upsteam of EcoRI site, forward
                     primer"
     primer_bind     complement(16376..16398)
                     /label="pGEX 3'"
                     /note="pGEX vectors, reverse primer"
     primer_bind     16498..16517
                     /label="pRS-marker"
                     /note="pRS vectors, use to sequence yeast selectable
                     marker"